Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

AbbVie CEO Gonzalez defends Allergan takeover

AbbVie CEO Gonzalez defends Allergan takeover

Richard Gonzalez. He downplayed the risks to Allergan’s Botox from branded rivals such as Evolus’ Jeuveau or biosimilars. ... reasons “it's highly unlikely that we would see a biosimilar against Botox for a long, long time, if ever.”.

AbbVie to acquire Allergan for $63bn

AbbVie to acquire Allergan for $63bn The company says the deal will significantly expand and diversify its revenue base with new therapeutic areas, including Allergan's leading medical aesthetics business, most notably Botox, which earned $3.7bn

CHMP nod for Alexion, GSK drugs, revocation for Lartruvo

CHMP nod for Alexion, GSK drugs, revocation for Lartruvo Nuceiva (botulinum toxin type a), a facial filler for vertical lines between the eyebrows, a new rival for Allergan’s Botox.

Allergan wins support against dissident shareholders

Allergan wins support against dissident shareholders of its women's health unit and face competitive threats to top sellers such as Botox.

Teva’s migraine injection approved in Europe

Teva’s migraine injection approved in Europe The FDA also recently accepted an NDA from Botox developer Allergan, which filed its oral CGRP ubrogepant for the acute treatment of migraine in adults.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics